OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The enhancement of recombinant antibody production in Chinese Hamster Ovary (CHO) cells is a crucial aspect of biopharmaceutical development. To maximize efficacy, various methods are employed, including genetic engineering of the host cells and optimization of growth conditions. Additionally, utilization of advanced bioreactors can significantly